2014年美国共有78家生物技术和制药公司IPO,比之前3年的总和还要多。其中13家公司来自湾区,这13家公司共募集12.9亿美元。自2000年以来,硅谷上市的公司每年不会超过9家,今年该地区公司的表现无疑是2000年来最佳。
详细英文介绍:
Today: Biotechnology companies enjoy their best year on the IPO market since the dot-com boom. The Lead: Biotech IPOs hit a new high
Biotechnology and pharmaceutical companies enjoyed a banner year in 2014, with initial public offerings hitting their highest point of the millennium.
Data provided by Ipreo, a market intelligence firm, shows that there were more IPOs from biotech and biopharmaceutical companies in 2014 than in the previous three years combined, both in the United States and from Silicon Valley. Nationwide, 78 such companies went public this year; 13 of those firms were from the Bay Area, and they brought in $1.29 billion total.
That performance blew away previous highs recorded since 2000. Silicon Valley had not produced more than 9 biotech IPOs in a year since the dot-com boom went bust in 2000, and the previous high for the U.S. was set in 2013, with 46. In the three previous years combined, the U.S. had 66 biotech IPOs, with 11 coming from the Bay Area and totaling $875.7 million.